F. Haverkamp

933 total citations
40 papers, 510 citations indexed

About

F. Haverkamp is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, F. Haverkamp has authored 40 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Molecular Biology. Recurrent topics in F. Haverkamp's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Parvovirus B19 Infection Studies (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). F. Haverkamp is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Parvovirus B19 Infection Studies (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). F. Haverkamp collaborates with scholars based in Germany, United States and Poland. F. Haverkamp's co-authors include Meinolf Noeker, Klaus Zerres, D. Emons, R. Roßkamp, Hubert Fahnenstich, Burkhard Kreft, Joachim Woelfle, Peter Bartmann, Michael B. Ranke and J. Dembinski and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Investigative Ophthalmology & Visual Science and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

F. Haverkamp

35 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Haverkamp Germany 14 198 143 126 95 72 40 510
Kling Chong United Kingdom 14 181 0.9× 164 1.1× 132 1.0× 75 0.8× 45 0.6× 16 601
C Kennedy United Kingdom 12 116 0.6× 102 0.7× 39 0.3× 74 0.8× 18 0.3× 23 538
Alfonso Verdú Spain 13 100 0.5× 287 2.0× 61 0.5× 32 0.3× 56 0.8× 29 554
Faruk İncecik Türkiye 14 160 0.8× 89 0.6× 54 0.4× 31 0.3× 66 0.9× 86 587
P G Cleland United Kingdom 10 59 0.3× 113 0.8× 50 0.4× 87 0.9× 26 0.4× 12 476
Şakìr Altunbaşak Türkiye 15 288 1.5× 71 0.5× 49 0.4× 47 0.5× 66 0.9× 91 809
Ignacio Málaga Spain 13 75 0.4× 137 1.0× 235 1.9× 18 0.2× 95 1.3× 47 950
Michael Karenfort Germany 13 84 0.4× 86 0.6× 65 0.5× 30 0.3× 37 0.5× 32 828
B M Laurance United Kingdom 13 173 0.9× 136 1.0× 225 1.8× 41 0.4× 17 0.2× 32 615
R. Dwain Blackston United States 11 303 1.5× 232 1.6× 279 2.2× 166 1.7× 10 0.1× 16 741

Countries citing papers authored by F. Haverkamp

Since Specialization
Citations

This map shows the geographic impact of F. Haverkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Haverkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Haverkamp more than expected).

Fields of papers citing papers by F. Haverkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Haverkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Haverkamp. The network helps show where F. Haverkamp may publish in the future.

Co-authorship network of co-authors of F. Haverkamp

This figure shows the co-authorship network connecting the top 25 collaborators of F. Haverkamp. A scholar is included among the top collaborators of F. Haverkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Haverkamp. F. Haverkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haverkamp, F., et al.. (2005). Leistungsmotivation bei Kindern mit Migräne und ihren gesunden Geschwistern. Klinische Pädiatrie. 217(4). 234–237. 1 indexed citations
2.
Haverkamp, F., et al.. (2003). Intraocular Pressure, Safety and Quality of Life in Glaucoma Patients Switching to Latanoprost from Adjunctive and Monotherapy Treatments. Investigative Ophthalmology & Visual Science. 44(13). 793–793. 2 indexed citations
3.
Dembinski, J., et al.. (2002). Neurodevelopmental outcome after intrauterine red cell transfusion for Parvovirus B19‐induced fetal hydrops. BJOG An International Journal of Obstetrics & Gynaecology. 109(11). 1232–1234. 48 indexed citations
4.
Haverkamp, F., et al.. (2002). Cognitive Development in Children with Migraine and Their Healthy Unaffected Siblings. Headache The Journal of Head and Face Pain. 42(8). 776–779. 40 indexed citations
5.
Zenker, Sven, et al.. (2002). Growth hormone deficiency in pituitary disease: relationship to depression, apathy and somatic complaints. European Journal of Endocrinology. 147(2). 165–171. 16 indexed citations
6.
Haverkamp, F., et al.. (2000). Good prognosis for psychomotor development in survivors with nonimmune hydrops fetalis. BJOG An International Journal of Obstetrics & Gynaecology. 107(2). 282–284. 13 indexed citations
7.
Noeker, Meinolf & F. Haverkamp. (2000). Adjustment in Conditions with Short Stature: A Conceptual Framework. Journal of Pediatric Endocrinology and Metabolism. 13(9). 1585–94. 27 indexed citations
8.
Haverkamp, F. & Michael B. Ranke. (1999). The Ethical Dilemma of Growth Hormone Treatment of Short Stature: A Scientific Theoretical Approach. Hormone Research in Paediatrics. 51(6). 301–304. 11 indexed citations
9.
Haverkamp, F., Joachim Wölfle, Klaus Zerres, et al.. (1999). Growth Retardation in Turner Syndrome: Aneuploidy, Rather Than Specific Gene Loss, May Explain Growth Failure. The Journal of Clinical Endocrinology & Metabolism. 84(12). 4578–4582. 26 indexed citations
10.
Haverkamp, F. & Meinolf Noeker. (1998). ‘Short stature in children - a questionnaire for parents’: a new instrument for growth disorder-specific psychosocial adaptation in children. Quality of Life Research. 7(5). 447–455. 25 indexed citations
11.
Woelfle, Joachim, Burkhard Kreft, D. Emons, & F. Haverkamp. (1996). Subdural hemorrhage as an initial sign of glutaric aciduria type 1: A diagnostic pitfall. Pediatric Radiology. 26(11). 779–781. 49 indexed citations
12.
Haverkamp, F., et al.. (1996). Nonimmune Hydrops fetalis with Galactosialidosis: Consequences for Family Planning. Fetal Diagnosis and Therapy. 11(2). 114–119. 12 indexed citations
13.
Haverkamp, F., et al.. (1996). Craniometaphyseal dysplasia as a rare cause of a severe neonatal nasal obstruction. International Journal of Pediatric Otorhinolaryngology. 34(1-2). 159–164. 10 indexed citations
14.
Haverkamp, F., et al.. (1995). Hereditäre motorisch-sensible Neuropathie Typ III. Klinische Pädiatrie. 207(1). 24–27.
15.
Haverkamp, F., et al.. (1991). Syndrome of developmental retardation, facial and skeletal anomalies, and hyperphosphatasia in two sisters: Nosology and genetics of the coffin‐siris syndrome. American Journal of Medical Genetics. 41(3). 350–354. 27 indexed citations
16.
Roßkamp, R., et al.. (1990). The Effect of Cyproheptadine on Plasma Growth Hormone (GH) and on Somatostatin Response to GH-Releasing Hormone in Man. Hormone and Metabolic Research. 22(5). 295–297. 2 indexed citations
17.
Bindl, L., D. Emons, F. Haverkamp, et al.. (1989). Das Megazystis-Mikrokolon-intestinale Hypoperistaltik-Syndrom: Eine Neuropathie?. European Journal of Pediatric Surgery. 44(4). 249–252. 8 indexed citations
18.
Haverkamp, F., Klaus Zerres, & R. Roßkamp. (1989). Three sibs with achalasia and alacrimia: A separate entity different from triple‐A syndrome. American Journal of Medical Genetics. 34(2). 289–291. 14 indexed citations
19.
Roßkamp, R., et al.. (1988). Plasma growth hormone-releasing hormone levels in type 1 (insulin-dependent) diabetic children following a mixed meal. Journal of Molecular Medicine. 66(6). 257–260. 1 indexed citations
20.
Roßkamp, R., et al.. (1987). Plasma levels of growth hormone-releasing hormone and somatostatin in response to a mixed meal and during sleep in children. European Journal of Endocrinology. 116(4). 549–554. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kling Chong Breakdown of academic impact, for papers by C Kennedy Breakdown of academic impact, for papers by Alfonso Verdú Breakdown of academic impact, for papers by Faruk İncecik Breakdown of academic impact, for papers by P G Cleland Breakdown of academic impact, for papers by Şakìr Altunbaşak Breakdown of academic impact, for papers by Ignacio Málaga Breakdown of academic impact, for papers by Michael Karenfort Breakdown of academic impact, for papers by B M Laurance Breakdown of academic impact, for papers by R. Dwain Blackston
Rankless by CCL
2026